Latest Stories
Why Norwegian Cruise Line (NCLH) Stock Is Trading Lower Today
Shares of cruise company Norwegian Cruise Line (NYSE:NCLH) fell 3.8% in the afternoon session after a recent analyst downgrade and broader concerns about the cruise industry weighed on the stock.
Why Asana (ASAN) Stock Is Nosediving
Shares of work management platform Asana (NYSE:ASAN) fell 6.1% in the afternoon session after disclosures showed its Chief Operating Officer, Anne Raimondi, sold approximately $2.3 million worth of company stock.
Why Marvell Technology (MRVL) Stock Is Trading Up Today
Shares of networking chips designer Marvell Technology (NASDAQ: MRVL) jumped 3.4% in the afternoon session after investment firm Citi issued a positive catalyst watch for the stock ahead of the upcoming Consumer Electronics Show (CES), contributing to a broader rally in the chip sector.
BioMarin Pharmaceutical (BMRN) Stock Is Up, What You Need To Know
Shares of biotech company BioMarin Pharmaceutical (NASDAQ:BMRN) jumped 2.6% in the afternoon session after the stock's positive momentum continued as the company agreed to acquire Amicus Therapeutics for a total equity value of about $4.8 billion, a move expected to boost future growth. BioMarin's President and CEO, Alexander Hardy, said the transaction was expected to accelerate the company's revenue growth and strengthen its financial outlook. The deal was viewed positively by analysts, with Truist Securities raising its price target on the stock to $100 from $80, noting the acquisition aligned with BioMarin's focus on rare diseases. In other news, the company also announced it had stopped the development of its investigational BMN 349 treatment for a specific type of liver disease.
Why Payoneer (PAYO) Shares Are Falling Today
Shares of cross-border payment platform Payoneer (NASDAQ:PAYO) fell 4.3% in the afternoon session after Benchmark lowered its price target on the stock, citing macroeconomic uncertainty. The financial services firm cut its price target on Payoneer to $10 from $12. The adjustment was linked to headwinds that faced the company's small and medium-sized business customers as they struggled to adapt to changing U.S. tariff policies. Despite the lower price target, Benchmark maintained its "Buy" rating on the company's shares.
Why Ibotta (IBTA) Shares Are Sliding Today
Shares of cash-back rewards platform Ibotta (NYSE:IBTA) fell 2.4% in the afternoon session after reports revealed that Cathie Wood's ARK Invest continued to sell its stake in the company. According to trade filings, ARK Invest sold 3,733 shares of the consumer tech company across two of its funds for a total value of about $81,379. This was not an isolated event, as the investment firm had been trimming its position in Ibotta over several days. Such consistent selling by a high-profile investor often raises concerns among other market participants about a company's outlook, creating downward pressure on the stock price.
Ryan Specialty’s (NYSE:RYAN) Q3 CY2025: Beats On Revenue
Insurance specialty broker Ryan Specialty (NYSE:RYAN) beat Wall Street’s revenue expectations in Q3 CY2025, with sales up 24.8% year on year to $754.6 million. Its non-GAAP profit of $0.47 per share was in line with analysts’ consensus estimates.
Marsh & McLennan (NYSE:MMC) Reports Q3 CY2025 In Line With Expectations
Professional services firm Marsh & McLennan (NYSE:MMC) met Wall Streets revenue expectations in Q3 CY2025, with sales up 11.5% year on year to $6.35 billion. Its non-GAAP profit of $1.85 per share was 4.1% above analysts’ consensus estimates.
Why Lucid (LCID) Stock Is Falling Today
Shares of luxury electric car manufacturer Lucid (NASDAQ:LCID) fell 4.4% in the morning session after prominent market commentator Jim Cramer recommended investors sell the stock.
Why Array (ARRY) Stock Is Down Today
Shares of solar tracking systems manufacturer Array (NASDAQ:ARRY) fell 4.3% in the morning session after the stock pulled back from a recent 52-week high, appearing to give back some of its recent gains.